The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Summer 2025 RFA: Personalized Approaches for Understanding, Assessing and Improving Gait in Parkinson’s Disease Research Program, 2026ADAPT-GAIT: Adaptive deep brain stimulation controlled by neural biomarkers of gait to alleviate locomotor deficits in people with advanced Parkinson's disease
Study Rationale:
People with advanced Parkinson’s disease often develop severe gait and balance impairments—including asymmetries, instability, and freezing of gait—that are heterogeneous...
-
Target Validation, 2014Validating BAG5 as a Therapeutic Target of Parkinson’s Disease
Objective/Rationale:
Poor handling and elimination of misfolded proteins has been identified as central in the development of Parkinson’s disease (PD). A special class of proteins within the cell... -
Target Validation, 2012Validation of Sirtuin 3 as a Neuroprotective Target in Parkinson’s Disease
Objective/Rationale:
Mitochondria are the major energy generators of a cell. Dysfunctional mitochondria are central to the pathology of Parkinson’s Disease (PD). We hypothesize that improving the...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.